Beta Bionics, Inc. — Director's Dealing 2025

Sep 5, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Beta Bionics, Inc. (BBNX)
CIK: 0001674632
Period of Report: 2025-09-02

Reporting Person: Mensinger Mike (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-09-02	Common Stock	S	1089	$18.8632	Disposed	91815	Direct

Footnotes

F1: The shares were sold to cover tax withholding obligations associated with the vesting of restricted stock units.

F2: The weighted average sale price for the transaction reported was $18.8632 and the range of prices were between $18.58 and $19.09. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.